FDA Issues

NHC Comments on PDUFA VII Public Stakeholder Meeting

By Maddie Mason, Senior Associate, Policy  The National Health Council (NHC) submitted comments last week to the Food and Drug Administration (FDA) on their July 23 Public Stakeholder Meeting on the Prescription Drug User Fee Act (PDUFA) VII where NHC […]

Read more